Schedule 13G ownership disclosure

BioLineRx Ltd.

Security class unavailable · CUSIP: 09071M106

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,781,641
Percent of class
7.4400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-18-000910
Form type
SC 13G/A
Filer
BioLineRx Ltd.
CIK
CIK 1498403
Filed
Feb 12, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub